2021 American Transplant Congress
Extracellular Vesicles from Patients with Diabetic Nephropathy Induce Endothelial Dysfunction Through Icam-1 and Vcam-1 in an In Vitro Model
*Purpose: Extracellular Vesicles (EVs) are membranous structures produced by cells which contain different cytoplasmic compounds and that have been described as potentially pathogenic elements in…2021 American Transplant Congress
Relationship Between Diabetes Mellitus and Covid-19 Prognosis in Kidney Transplant Patients
Department of Medicine, Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil
*Purpose: A high number of comorbidities associated with the severity of the disease caused by SARS-CoV-2 (COVID-19) has been reported, such as systemic arterial hypertension…2021 American Transplant Congress
Effect of Insulin versus Oral Agents on Early Glycemic Control Following Kidney Transplant
Mount Sinai Hospital, New York, NY
*Purpose: Insulin therapy is commonly prescribed to treat hyperglycemia early post-kidney transplant (KTx) due to its widespread availability and ease of titration. Alternatively, there is…2020 American Transplant Congress
Sequential Protocol Biopsies Post-Liver Transplant from Donors with Moderate Macrosteatosis: What Happens to the Fat?
Mayo Clinic Jacksonville, Jacksonville, FL
*Purpose: The number of steatotic deceased donor livers encountered has continued to rise as a result of the obesity epidemic. Little is known about the…2020 American Transplant Congress
Characterization of Use and Safety of Non-Insulin Agents for Management of Post-Transplant Diabetes Mellitus in the Kidney Transplant Population
*Purpose: Newer, non-insulin agents appear to have significant cardiovascular benefits. However, use of these agents for diabetes (DM) management in kidney transplant recipients (KTR) has…2020 American Transplant Congress
GLP1-RAs, SGLT2i Are Underutilized in Kidney Transplant Recipients with Diabetes Mellitus and Obesity
University of Virginia, Charlottesville, VA
*Purpose: There is little research describing differences in use of antidiabetic medications amongst obese, diabetic patients with or without a history of kidney transplant. More…2020 American Transplant Congress
Diabetes Burnout: An Under-Recognized Risk-Factor in Post-Transplant Care Management
Medical University of South Carolina, Charleston, SC
*Purpose: One-third of dialysis patients will have spontaneous glycemic control improvement, necessitating discontinuation of antihyperglycemic therapy, termed diabetes burnout. The aim of this study was…2020 American Transplant Congress
Cardiovascular Risk Factors in Patients after Liver Transplantion
*Purpose: The aim of this study was to estimate the prevalence of selected cardiovascular risk factors in patients after liver transplantation (LTx).*Methods: Medical records from…2020 American Transplant Congress
Progression of Insulin Resistance after Liver Transplantation – Prospective Study
*Purpose: Insulin resistance (IR) plays an important role in pathogenesis of nonalcoholic fatty liver disease (NAFLD) and other diseases. The data about prevalence and evolution…2020 American Transplant Congress
New-Onset Diabetes after Adult Liver Transplantation in the Korean Organ Transplantation Registry Study
*Purpose: New-onset diabetes after transplantation (NODAT) is a serious complication following liver transplantation (LT). The present study aimed to investigate the incidence of and risk…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 7
- Next Page »